Clinical Trials Sponsored by Corbridge Group Philippines, Inc.
Total 1 results
-
Corbridge Group Philippines, Inc.Alfasigma S.p.A.UnknownChronic Kidney DiseasePhilippines
Sponsors and Collaborators
- Societa Italiana di Endoscopia Digestiva
- Rui-hua Xu, MD, PhD
- University Centre for Chronic Diseases Dekkerswald, Groesbeek, NL
- Celtaxsys Aus Pty Limited
- Cardresearch
- AMTC & Associates
- University Medical Center Goettingen
- Donders Institute for Brain, Cognition and Behavior
- Fondren Orthopedic Group L.L.P.
- Caritas Freetown
- CRMBM-CEMEREM
- Alberta Children's Hospital, Calgary, Canada
- San MediTech(Huzhou)Co.,Ltd.
- Elim Pediatric Pharmaceuticals Inc.
- Victor Montori
- Norsk Proteinintolerance, Norway
- Ilustre Colegio Profesional de Fisioterapeutas de la Comunidad de Madrid
- Diego Hernan Giunta, MD
- The Fifth Affiliated Hospital of Zunyi Medical College
- ProteoSys AG
- View Full List
Medical Conditions
- Tube Disorders Eustachian
- Orbital Tumor
- Fibromyalgia Syndrome, Primary
- Malignant Ascites Due to Epithelial Carcinoma
- Non-compressible Torso Hemorrhage
- Spermatogenesis Arrest
- Fever, Sweats, and Hot Flashes
- Disturbance of Activity and Attention
- Non-dystrophic Myotonias
- Lymphedema of Arm
- Postcomatose Unawareness State
- Prostate Cancer Recurrent
- Stereotactic Radioablation for Ventricular Tachycardia
- Auditory Hallucination, Verbal
- Plasmodium Falciparum Malaria (Drug Resistant)
- Gynecologic Cancer
- Analgesics, Antipyretics, and Antirheumatics Causing Adverse Effects in Therapeutic Use
- Tularaemia
- Normal Diameter of Optic Nerve
- Atrial Fibrillation, Postoperative
- View Full List
Drug Interventions
- Indoximod
- Epimedium Prenylflavonoids Extract
- SERETIDE Diskus
- Flibanserin 100 mg dose every evening
- Mupirocin Calcium
- Cetrorelix 78 mg + 78 mg
- Polyethylene glycol 3350
- CTx-1301-Dexmethylphenidate 18.75mg (randomized fixed dose)
- Ruxolitinib
- Topotecan
- Oxycodone, fentanyl
- Cytarabine ARA-C
- Insulin
- Enzalutamide, Abiraterone
- Methotrexate
- HB-202 / HB-201 alternating intravenous administration + standard of care regimen including pembrolizumab.
- Atezolizumab
- PF-00868554
- Bortezomib/dexamethasone
- Lamivudine
- View Full List
CROs by country
- Contract Research Organizations in Argentina
- Contract Research Organizations in Brazil
- Contract Research Organizations in Colombia
- Contract Research Organizations in Cote d'Ivoire
- Contract Research Organizations in Croatia
- Contract Research Organizations in Djibouti
- Contract Research Organizations in Greece
- Contract Research Organizations in Guinea
- Contract Research Organizations in Ireland
- Contract Research Organizations in Malawi
- Contract Research Organizations in Montenegro
- Contract Research Organizations in Peru
- Contract Research Organizations in Ukraine
- CRO list by country